JP2921730B2 - Gelling agent for organic solvents or fats and oils - Google Patents
Gelling agent for organic solvents or fats and oilsInfo
- Publication number
- JP2921730B2 JP2921730B2 JP6787494A JP6787494A JP2921730B2 JP 2921730 B2 JP2921730 B2 JP 2921730B2 JP 6787494 A JP6787494 A JP 6787494A JP 6787494 A JP6787494 A JP 6787494A JP 2921730 B2 JP2921730 B2 JP 2921730B2
- Authority
- JP
- Japan
- Prior art keywords
- fats
- oils
- gelling agent
- organic solvents
- leucine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003921 oil Substances 0.000 title claims description 32
- 239000003349 gelling agent Substances 0.000 title claims description 30
- 239000003925 fat Substances 0.000 title claims description 26
- 239000003960 organic solvent Substances 0.000 title claims description 26
- 108010016626 Dipeptides Proteins 0.000 claims description 32
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 32
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 30
- 125000004122 cyclic group Chemical group 0.000 claims description 29
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 13
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 13
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 9
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 5
- 229960000310 isoleucine Drugs 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 4
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims description 3
- 101150065749 Churc1 gene Proteins 0.000 claims description 3
- 102100038239 Protein Churchill Human genes 0.000 claims description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- 235000019198 oils Nutrition 0.000 description 30
- 239000000499 gel Substances 0.000 description 26
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- 229960003136 leucine Drugs 0.000 description 17
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- 229940024606 amino acid Drugs 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- -1 amino acid compounds Chemical class 0.000 description 9
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 8
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 8
- 239000003549 soybean oil Substances 0.000 description 8
- 235000012424 soybean oil Nutrition 0.000 description 8
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 229960005190 phenylalanine Drugs 0.000 description 7
- 229960004295 valine Drugs 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- 239000004395 L-leucine Substances 0.000 description 6
- 235000019454 L-leucine Nutrition 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 4
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229940093609 tricaprylin Drugs 0.000 description 4
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 4
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 4
- 229940117972 triolein Drugs 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XCTHZFGSVQBHBW-IUCAKERBSA-N Val-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])C(C)C XCTHZFGSVQBHBW-IUCAKERBSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- QIGLJVBIRIXQRN-ZETCQYMHSA-N ethyl (2s)-2-amino-4-methylpentanoate Chemical compound CCOC(=O)[C@@H](N)CC(C)C QIGLJVBIRIXQRN-ZETCQYMHSA-N 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- XWYXUMDVQIOAPR-UHFFFAOYSA-N (3S,6S)-3,6-Diisobutyl-2,5-dioxohexahydropyrazine Natural products CC(C)CC1NC(=O)C(CC(C)C)NC1=O XWYXUMDVQIOAPR-UHFFFAOYSA-N 0.000 description 2
- QPDMOMIYLJMOQJ-UHFFFAOYSA-N Cyclo-L-leu-L-phe Natural products N1C(=O)C(CC(C)C)NC(=O)C1CC1=CC=CC=C1 QPDMOMIYLJMOQJ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000007112 amidation reaction Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003849 aromatic solvent Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- XWYXUMDVQIOAPR-UWVGGRQHSA-N cyclo(L-leucyl-L-leucyl) Chemical compound CC(C)C[C@@H]1NC(=O)[C@H](CC(C)C)NC1=O XWYXUMDVQIOAPR-UWVGGRQHSA-N 0.000 description 2
- QPDMOMIYLJMOQJ-STQMWFEESA-N cyclo(L-phenylalanyl-L-leucyl) Chemical compound N1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CC1=CC=CC=C1 QPDMOMIYLJMOQJ-STQMWFEESA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 2
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FMZUHGYZWYNSOA-VVBFYGJXSA-N (1r)-1-[(4r,4ar,8as)-2,6-diphenyl-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound C([C@@H]1OC(O[C@@H]([C@@H]1O1)[C@H](O)CO)C=2C=CC=CC=2)OC1C1=CC=CC=C1 FMZUHGYZWYNSOA-VVBFYGJXSA-N 0.000 description 1
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- CANZBRDGRHNSGZ-NSHDSACASA-N (2s)-3-methyl-2-(phenylmethoxycarbonylamino)butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 CANZBRDGRHNSGZ-NSHDSACASA-N 0.000 description 1
- WTKQMHWYSBWUBE-UHFFFAOYSA-N (3-nitropyridin-2-yl) thiohypochlorite Chemical group [O-][N+](=O)C1=CC=CN=C1SCl WTKQMHWYSBWUBE-UHFFFAOYSA-N 0.000 description 1
- UPOUGDHEEGKEGS-UHFFFAOYSA-N (3S,6S)-3-(1-methylethyl)-6-(2-methylpropyl)piperazine-2,5-dione Natural products CC(C)CC1NC(=O)C(C(C)C)NC1=O UPOUGDHEEGKEGS-UHFFFAOYSA-N 0.000 description 1
- QGMAWEIDGADSAC-YUMQZZPRSA-N (3s,6s)-3,6-di(propan-2-yl)piperazine-2,5-dione Chemical compound CC(C)[C@@H]1NC(=O)[C@H](C(C)C)NC1=O QGMAWEIDGADSAC-YUMQZZPRSA-N 0.000 description 1
- UPOUGDHEEGKEGS-IUCAKERBSA-N (3s,6s)-3-(2-methylpropyl)-6-propan-2-ylpiperazine-2,5-dione Chemical compound CC(C)C[C@@H]1NC(=O)[C@H](C(C)C)NC1=O UPOUGDHEEGKEGS-IUCAKERBSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- WZEYZMKZKQPXSX-UHFFFAOYSA-N 1,3,5-trimethylbenzene Chemical compound CC1=CC(C)=CC(C)=C1.CC1=CC(C)=CC(C)=C1 WZEYZMKZKQPXSX-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- RFCVXVPWSPOMFJ-STQMWFEESA-N Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RFCVXVPWSPOMFJ-STQMWFEESA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002635 aromatic organic solvent Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 108010049972 cyclo-(Val-Leu) Proteins 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940087101 dibenzylidene sorbitol Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Fats And Perfumes (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、特定のアミノ酸からな
る環状ジペプチドを有効成分とする有機溶媒あるいは油
脂類のゲル化剤に係わる。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a gelling agent for organic solvents or fats and oils containing a cyclic dipeptide comprising a specific amino acid as an active ingredient.
【0002】[0002]
【従来の技術】従来、水性系のゲル化剤に比べて油性系
のゲル化剤に関する研究、報告は数多く見当たらなかっ
た。しかし、近年、油性系ゲル化剤の中ではひまし油を
原料として得られる12−ヒドロキシステアリン酸が廃
油処理剤として上市され、この分野での開発は最近とみ
に進んでいる。ただし12−ヒドロキシステアリン酸は
ゲル化させる油性物質の種類が限られており、得られる
ゲルの感触もボソついたものになりやすく、その応用範
囲が狭いことが難点であった。2. Description of the Related Art Heretofore, there have not been many studies and reports on oil-based gelling agents as compared with aqueous gelling agents. However, in recent years, among the oil-based gelling agents, 12-hydroxystearic acid obtained from castor oil as a raw material has been marketed as a waste oil treating agent, and development in this field has been progressing recently. However, 12-hydroxystearic acid is limited in the type of oily substance to be gelled, and the resulting gel tends to have a rough feel, and its application range is narrow.
【0003】一方、これらの問題点を解決するために各
種のアミノ酸を利用したゲル化剤(例えばN−ラウロイ
ル−L−グルタミン酸−α,γ−ジ−n−ブチルアミ
ド)が開発されている。これはアミノ酸そのものを化学
的に変性させることにより、あるいはアミノ基やカルボ
キシル基等の官能基に反応させる物質を選択することに
より、様々な有機溶剤ならびに油脂をゲル化せしめる化
合物を得ることができるものである。またそのゲル強度
に関しても、前記と同様の処理を施しアミノ酸誘導体を
調製することにより調節できることから、数多くの検討
がなされている。しかしながら、これらのアミノ酸系油
性ゲル化剤は、例えば特開昭51−91884号公報に
記載されているような直鎖状型ペプチド誘導体が中心で
あった。また、これらのペプチド誘導体では、ゲル化能
力および得られるゲルの感触等については必ずしも満足
できるものではなかった。On the other hand, to solve these problems, gelling agents utilizing various amino acids (for example, N-lauroyl-L-glutamic acid-α, γ-di-n-butylamide) have been developed. This is a compound that can gel various organic solvents and fats and oils by chemically modifying amino acids themselves or by selecting substances that react with functional groups such as amino groups and carboxyl groups. It is. Also, the gel strength has been studied a lot because it can be adjusted by preparing the amino acid derivative by performing the same treatment as described above. However, these amino acid-based oil-based gelling agents have mainly been linear peptide derivatives as described in, for example, JP-A-51-91884. In addition, these peptide derivatives were not always satisfactory with respect to gelling ability and feeling of the obtained gel.
【0004】[0004]
【発明が解決しようとする課題】本発明者らは、かかる
現状を踏まえ、各種アミノ酸系化合物を作成し、そのゲ
ル形成能等について詳細に比較検討した結果、本発明を
完成するに至ったものである。すなわち本発明は、従来
の油性系ゲル化剤に比べてゲル化能に優れ、感触の良好
なゲルを形成するゲル化剤を提供することを目的とす
る。SUMMARY OF THE INVENTION The present inventors have made various amino acid compounds based on the present situation, and have conducted detailed comparison of the gel forming ability and the like. As a result, the present inventors have completed the present invention. It is. That is, an object of the present invention is to provide a gelling agent which is excellent in gelling ability as compared with conventional oil-based gelling agents and forms a gel having a good feel.
【0005】[0005]
【課題を解決するための手段】前記目的を達成するため
に、本発明は、ロイシンと、バリン、ロイシン、イソロ
イシンおよびフェニルアラニンからなる群より選ばれる
1種との下記一般式(1)で示される環状ジペプチドを
有効成分とするゲル化剤、をその要旨とする。In order to achieve the above object, the present invention provides a compound represented by the following general formula (1) comprising leucine and one selected from the group consisting of valine, leucine, isoleucine and phenylalanine. The gist of the present invention is a gelling agent containing a cyclic dipeptide as an active ingredient.
【化5】 〔ただし式(1)中、Aは(CH3 )2 CH、(C
H3 )2 CHCH2 、(C2H5 )(CH3 )CHまた
はEmbedded image [However, in the formula (1), A is (CH 3 ) 2 CH, (C
H 3) 2 CHCH 2, ( C 2 H 5) (CH 3) CH or
【化6】 である。〕Embedded image It is. ]
【0006】本発明のゲル化剤において必須とする成分
は、脂肪族中性アミノ酸であるロイシンと、脂肪族また
は芳香族中性アミノ酸であるバリン、ロイシン、イソロ
イシンおよびフェニルアラニンからなる群より選ばれる
1種とが2個のアミド結合によって六員環構造を形成し
た環状ジペプチドである。かかる環状ジペプチドは前記
一般式(1)で示される。The essential component in the gelling agent of the present invention is selected from the group consisting of leucine, an aliphatic neutral amino acid, and valine, leucine, isoleucine and phenylalanine, which are aliphatic or aromatic neutral amino acids. A species is a cyclic dipeptide in which a six-membered ring structure is formed by two amide bonds. Such a cyclic dipeptide is represented by the general formula (1).
【0007】本発明の環状ジペプチドの原料アミノ酸
は、天然物由来の蛋白質の酸、アルカリもしくは酵素に
よる加水分解物を抽出して得られるもの、微生物の発酵
や培養産生物から分離したもの、または化学合成法によ
って得られるもののいずれでもよい。また、その光学異
性体はD体、L体およびDL体(ラセミ体)の差を問わ
ず使用することができるが、工業用原料として汎用的に
市販されているL体またはDL体が安価に入手でき、至
便である。The starting amino acids of the cyclic dipeptides of the present invention include those obtained by extracting acid, alkali or enzymatic hydrolysates of proteins derived from natural products, those isolated from fermentation and culture products of microorganisms, and those obtained by chemicals. Any of those obtained by the synthesis method may be used. The optical isomers can be used irrespective of the difference between the D-form, L-form and DL-form (racemic form). Available and convenient.
【0008】本発明の環状ジペプチドは、前記アミノ酸
を適宜選択して公知の方法を用いて合成することができ
る。例えば、前記脂肪族または芳香族中性アミノ酸は、
官能基のひとつであるα−アミノ基を保護したのち、ロ
イシンとアミド化反応を行ないジペプチドを形成せし
め、ついでα−アミノ基の保護基を脱離させ、最終的に
環状ジペプチドを形成せしめる。このための保護基とし
てはベンジルオキシカルボニル基(Z基)、t−ブトキ
シカルボニル基(Boc基)、9−フルオレニルメトキ
シカルボニル基(Fmoc基)、3−ニトロ−2−ピリ
ジンスルフェニル基(Npys基)など数多く存在する
が、脱離が容易なZ基を導入することが一般的である。
Z基の導入は塩化ベンジルオキシカルボニル(Z−C
l)を用い、Schoftten-Baumann 反応により、水酸化ナ
トリウム水溶液と同時に反応させる。[0008] The cyclic dipeptide of the present invention can be synthesized by appropriately selecting the amino acids and using a known method. For example, the aliphatic or aromatic neutral amino acid is
After protecting the α-amino group which is one of the functional groups, amidation reaction with leucine is carried out to form a dipeptide, and then the protecting group of the α-amino group is eliminated, and finally a cyclic dipeptide is formed. As a protecting group for this, a benzyloxycarbonyl group (Z group), a t-butoxycarbonyl group (Boc group), a 9-fluorenylmethoxycarbonyl group (Fmoc group), a 3-nitro-2-pyridinesulfenyl group ( Npys group) and the like, but it is common to introduce a Z group which can be easily removed.
Introduction of the Z group can be carried out by benzyloxycarbonyl chloride (ZC
Using l), a reaction is performed simultaneously with an aqueous solution of sodium hydroxide by a Schoftten-Baumann reaction.
【0009】ついで、前記したロイシンとZ基を導入し
た前記中性アミノ酸とを、ジシクロカルボジイミド(D
CC)を用いて40℃で約半日間アミド化反応せしめ、
直鎖状ジペプチド誘導体を調製し、これを炭素数5〜1
0程度の炭化水素を溶媒として、パラジウム炭素、ニッ
ケル、白金等の触媒の存在下、室温付近で数時間、水素
ガスを吹き込んで脱保護基化する。このように脱保護基
の方法としては他にもトリフルオロ酢酸や無水フッ化水
素による酸処理方法が一般的であるが、短鎖のペプチド
からの脱離の場合は穏和な接触還元法がよく用いられ
る。該反応物から前記触媒を除去した後、メシチレン、
ジオキサン、ジクロロメタン、テトラヒドロフラン等に
溶解し、数時間、還流させることにより、本発明の環状
ジペプチド(ロイシンと前記中性アミノ酸との環状化
物)を結晶として得ることができる。なお該環状ジペプ
チドは、メタノール、エタノール等の低級アルコール類
を溶媒として再結晶すればさらに高純度化することがで
きる。Next, the above-described leucine and the neutral amino acid into which the Z group has been introduced are combined with dicyclocarbodiimide (D
Amidation reaction at 40 ° C. for about half a day using CC),
A linear dipeptide derivative is prepared, and this is
Hydrogen gas is blown for several hours at about room temperature in the presence of a catalyst such as palladium carbon, nickel, or platinum using a hydrocarbon of about 0 as a solvent to perform deprotection. In this way, other methods of deprotection are generally acid treatment with trifluoroacetic acid or hydrogen anhydride, but in the case of elimination from short-chain peptides, a mild catalytic reduction method is often used. Used. After removing the catalyst from the reaction, mesitylene,
The cyclic dipeptide of the present invention (a cyclized product of leucine and the above-mentioned neutral amino acid) can be obtained as crystals by dissolving in dioxane, dichloromethane, tetrahydrofuran or the like and refluxing for several hours. The cyclic dipeptide can be further purified by recrystallization using a lower alcohol such as methanol or ethanol as a solvent.
【0010】本発明の環状ジペプチドは種々の有機溶媒
あるいは油脂類をゲル化せしめるが、とりわけハロゲン
系および芳香族系有機溶媒に対しては、ロイシンと、ロ
イシン、イソロイシンおよびフェニルアラニンのうちの
いずれかとの環状ジペプチドが好ましく、とくにロイシ
ンとフェニルアラニンとの環状ジペプチドがよい。また
油脂類に対しては、ロイシンとフェニルアラニンとの環
状ジペプチドがより好ましい。The cyclic dipeptide of the present invention gels various organic solvents or fats and oils. Particularly, for halogen and aromatic organic solvents, leucine and any one of leucine, isoleucine and phenylalanine are used. A cyclic dipeptide is preferred, and a cyclic dipeptide of leucine and phenylalanine is particularly preferred. For oils and fats, a cyclic dipeptide of leucine and phenylalanine is more preferable.
【0011】かくして得られる各種環状ジペプチドは、
この1種または2種以上を適宜に使用して本発明のゲル
化剤とすることができる。さらに本発明のゲル化剤に
は、前記環状ジペプチドのほかに公知のゲル化剤、増粘
剤、ワックス類等を含有せしめてもよい。公知のゲル化
剤としては、ペクチン、アルギン酸ソーダ、カラギーナ
ン、ポリアクリル酸もしくはポリメタクリル酸ナトリウ
ム等の水性系ゲル化剤があり、またモクロウ、12−ヒ
ドロキシステアリン酸、N−ラウロイル−L−グルタミ
ン酸−α,γ−ジ−n−ブチルアミド等のN−アシル−
アミノ酸−アルキルアミド、新油性ショ糖脂肪酸エステ
ル、デキストリン脂肪酸エステル、デンプン脂肪酸エス
テル、ジベンジリデンソルビトール、ジベンジリデンキ
シリトール、アクリル酸もしくはメタクリル酸系ポリマ
ー等の油性系ゲル化剤がある。The various cyclic dipeptides thus obtained are
One or more of these can be used as appropriate to form the gelling agent of the present invention. Further, the gelling agent of the present invention may contain known gelling agents, thickeners, waxes and the like in addition to the cyclic dipeptide. Known gelling agents include aqueous gelling agents such as pectin, sodium alginate, carrageenan, polyacrylic acid or sodium polymethacrylate, and also mocro, 12-hydroxystearic acid, N-lauroyl-L-glutamic acid- N-acyl- such as α, γ-di-n-butylamide
There are oil-based gelling agents such as amino acid-alkylamides, lipophilic sucrose fatty acid esters, dextrin fatty acid esters, starch fatty acid esters, dibenzylidene sorbitol, dibenzylidene xylitol, acrylic acid or methacrylic acid polymers.
【0012】公知の増粘剤としてアラビアガム、キサン
タンガム、グアーガム、トラガントガム、ローカストビ
ーンガム、カードラン、ジェランガム、亜麻種子粘質
物、カルボキシメチルセルロース、ヒドロキシエチルセ
ルロース、ヒドロキシプロピルメチルセルロース等を例
示できる。また公知のワックス類としては、カルナウバ
ワックス、キャンデリラワックス、シェラックロウ、ミ
ツロウ、シュガーケンワックス、ライスワックス、綿実
ワックス、ヒマワリワックス、パラフィンワックス、モ
ンタンワックス、ベイベリーワックス等を具体例として
あげることができる。Examples of known thickeners include gum arabic, xanthan gum, guar gum, tragacanth gum, locust bean gum, curdlan, gellan gum, flaxseed gum, carboxymethylcellulose, hydroxyethylcellulose and hydroxypropylmethylcellulose. Examples of known waxes include carnauba wax, candelilla wax, shellac wax, beeswax, sugarken wax, rice wax, cottonseed wax, sunflower wax, paraffin wax, montan wax, and bayberry wax. be able to.
【0013】本発明のゲル化剤は、前記環状ジペプチド
を20〜100重量%、好ましくは50〜100重量%
配合してなるものである。20重量%未満では、従来の
油性系ゲル化剤に比べて効果的なゲル化能を示すことが
できず、あるいは感触の良好なゲルを得にくくなる。本
発明のゲル化剤は、有機溶媒あるいは油脂類に対し、
0.1〜10重量/容量%(有機溶媒または油脂類の単
位容量:mlに対する本発明のゲル化剤の添加重量:gの
百分率を示す。以下同じ。)、好ましくは0.1〜5重
量/容量%添加して良好なゲル化能を有する。0.1重
量/容量%未満ではゲルが得られず、10重量/容量%
を超過すると結晶化傾向が大きくなる。The gelling agent of the present invention comprises the cyclic dipeptide in an amount of 20 to 100% by weight, preferably 50 to 100% by weight.
It is made by blending. If the amount is less than 20% by weight, it is not possible to exhibit an effective gelling ability as compared with a conventional oil-based gelling agent, or it is difficult to obtain a gel having a good feel. The gelling agent of the present invention, for organic solvents or fats and oils,
0.1 to 10% by weight / volume (unit weight of organic solvent or oil / fat: The addition weight of the gelling agent of the present invention per ml: Percentage of g is shown. The same applies hereinafter.), Preferably 0.1 to 5% by weight. /% By volume to have good gelling ability. If less than 0.1% by weight / volume, no gel can be obtained and 10% by weight / volume
If it exceeds, the crystallization tendency becomes large.
【0014】本発明においては種々の有機溶媒が対象と
なるが、とりわけハロゲン系溶媒および芳香族系溶媒と
くにベンゼン系溶媒が好ましく、この具体例として四塩
化炭素、ベンゼン、トルエン、キシレン、メトキシベン
ゼン、クロルベンゼン、ニトロベンゼン等がある。また
油脂類としては、常温にて好ましくは液状ないし半固体
状、より好ましくは液状を呈するものであって、大豆
油、菜種油、コーン油、サフラワー油、ヒマワリ油、綿
実油、オリーブ油、パーム油、アマニ油、ヒマシ油、魚
油、豚脂、牛脂、およびこれらを混合、分別あるいはエ
ステル交換した加工油脂等を例示でき、さらにトリアセ
チン、トリブチリン、トリカプリリン、カプリル酸およ
びカプリン酸の混合脂肪酸からなるトリグリセリド等の
炭素数2〜10程度の単一もしくは混合脂肪酸を構成脂
肪酸とするグリセリド類(ジクリセリド、モノグリセリ
ドを含んでいてもよい)を対象とすることができる。In the present invention, various organic solvents can be used. Halogen solvents and aromatic solvents are particularly preferable, and benzene solvents are preferable. Specific examples thereof include carbon tetrachloride, benzene, toluene, xylene, methoxybenzene, and the like. Chlorobenzene, nitrobenzene and the like. The fats and oils are preferably liquid to semi-solid at room temperature, and more preferably exhibit a liquid state, and are soybean oil, rapeseed oil, corn oil, safflower oil, sunflower oil, cottonseed oil, olive oil, palm oil, Linseed oil, castor oil, fish oil, lard, beef tallow, and processed fats and the like obtained by mixing, fractionating, or transesterifying them, and further include triacetin, tributyrin, tricaprylin, triglyceride comprising a mixed fatty acid of caprylic acid and capric acid, and the like Glycerides containing a single or mixed fatty acid having about 2 to 10 carbon atoms as a constituent fatty acid (may include diglyceride and monoglyceride).
【0015】本発明のゲル化剤を前記有機溶媒あるいは
油脂類に所定量添加し、要すれば約40〜80℃に加熱
し、攪拌して混合、溶解せしめた後、常温付近(20〜
25℃)に静置すれば、ゲル化物を調製することができ
る。得られるゲル状物は、寒天やゼラチンのようなボソ
つきのあるものではなく、均一で滑らかな状態のもので
あり、常温で長期間保存しても液状部の発生がなく、該
混合系全体も流動化することはない。A predetermined amount of the gelling agent of the present invention is added to the above-mentioned organic solvent or fats and oils, and if necessary, the mixture is heated to about 40 to 80 ° C., stirred and mixed and dissolved.
(25 ° C.), a gelled product can be prepared. The resulting gel-like material is not a fragile material such as agar or gelatin, but is in a uniform and smooth state. There is no fluidization.
【0016】以下の合成例、実施例および比較例におい
て、%はとくにことわらない限り重量基準である。 合成例1 L−バリン58.6gを2N水酸化ナトリウム水溶液2
50mlに溶かし、エーテル50mlを溶媒として加え、氷
温下で10分攪拌した後、塩化ベンジルオキシカルボニ
ル85.3gと2N水酸化ナトリウム水溶液250mlと
を同時に10回に分けて添加した。この溶液を分液ロー
トに移し、エーテルで洗いながら水層部を分取した。こ
れに酢酸エチルを250ml程度加え、さらに1N塩酸6
00mlを加えて攪拌した。水洗を3回繰り返し、酢酸エ
チル層に硫酸マグネシウムを加え、水分を除去しこれを
濾紙で濾別した後、濾液をナスフラスコに入れ、酢酸エ
チルを減圧留去した。これに新たな酢酸エチル150ml
程度を温めながら加え、さらに石油エーテルを少量ずつ
加えながら振とうした。振とうしても液が濁る状態にな
るまで石油エーテルを加え、これを冷蔵庫にて放置して
再結晶を行い、Z化L−バリン(以下、Z−L−Val
と略す)70.8gを得た。一方、L−ロイシン30g
を無水エタノール300mlに懸濁して、氷水中で冷却し
ながら乾燥塩化水素ガスを導入し、ついで湿気を避けて
室温で放置することにより塩酸塩を得、これを冷エタノ
ールと無水エーテルで順次洗浄、減圧乾燥した後、エタ
ノールとエーテルで再結晶してL−ロイシンエチルエス
テル〔以下、L−Leu(O−Et)と略す〕23.5
gを得た。In the following Synthesis Examples, Examples and Comparative Examples,% is by weight unless otherwise specified. Synthesis Example 1 58.6 g of L-valine was added to a 2N aqueous solution of sodium hydroxide 2
The mixture was dissolved in 50 ml, and ether (50 ml) was added as a solvent. After stirring at ice temperature for 10 minutes, 85.3 g of benzyloxycarbonyl chloride and 250 ml of a 2N aqueous sodium hydroxide solution were simultaneously added in 10 portions. This solution was transferred to a separating funnel, and the aqueous layer was separated while washing with ether. To this, add about 250 ml of ethyl acetate, and further add 1N hydrochloric acid 6
00 ml was added and stirred. Washing with water was repeated three times, and magnesium sulfate was added to the ethyl acetate layer to remove water. The water was removed by filtration with filter paper. The filtrate was placed in an eggplant flask, and ethyl acetate was distilled off under reduced pressure. Add 150ml of new ethyl acetate
The mixture was added while warming, and shaken while adding petroleum ether little by little. Petroleum ether is added until the liquid becomes turbid even after shaking, and this is left to cool in a refrigerator to recrystallize, and Z-L-valine (hereinafter, ZL-Val) is added.
70.8 g). On the other hand, L-leucine 30g
Was suspended in 300 ml of absolute ethanol, dried hydrogen chloride gas was introduced while cooling in ice water, and then allowed to stand at room temperature while avoiding moisture to obtain a hydrochloride, which was washed with cold ethanol and anhydrous ether successively. After drying under reduced pressure, the product was recrystallized from ethanol and ether and L-leucine ethyl ester [hereinafter abbreviated as L-Leu (O-Et)] 23.5.
g was obtained.
【0017】次にL−Leu(O−Et)とZ−L−V
alとの反応を行った。ナスフラスコにZ−L−Val
25.1gと酢酸エチル400mlを加え、氷浴中で攪拌
した。これにジシクロヘキシルカルボジイミド22.7
gを加えて室温で1時間攪拌することにより系は白濁し
た。この状態でL−Leu(O−Et)19.8gを加
え1時間攪拌し、さらに40℃まで加温した後に一晩反
応を続けた。この反応液に酢酸エチル800mlを加え、
加熱攪拌後、生じた沈殿部を除去し、酢酸エチルを減圧
留去して再度結晶化させた。冷却後、吸引濾過して結晶
を得、濾液は酢酸エチル800mlに溶かした後、同様に
処理して結晶を得、両結晶をあわせた。これを真空乾燥
することにより、L−ロイシンエチルエステルとZ−L
−Valとの直鎖状ジペプチド誘導体〔以下、Z−L−
Val−L−Leu(O−Et)と略す〕を16.1g
得た。Next, L-Leu (O-Et) and ZLV
The reaction with al was performed. Add ZL-Val to the eggplant flask.
25.1 g and 400 ml of ethyl acetate were added, and the mixture was stirred in an ice bath. In addition, dicyclohexylcarbodiimide 22.7
g was added and stirred at room temperature for 1 hour, whereby the system became cloudy. In this state, 19.8 g of L-Leu (O-Et) was added, the mixture was stirred for 1 hour, and further heated to 40 ° C., and the reaction was continued overnight. 800 ml of ethyl acetate was added to the reaction solution,
After heating and stirring, the resulting precipitate was removed, and ethyl acetate was distilled off under reduced pressure to recrystallize. After cooling, suction filtration was performed to obtain crystals. The filtrate was dissolved in 800 ml of ethyl acetate, and treated in the same manner to obtain crystals, and both crystals were combined. This is vacuum dried to obtain L-leucine ethyl ester and ZL
-Val and a linear dipeptide derivative [hereinafter, ZL-
Val-L-Leu (O-Et)].
Obtained.
【0018】Z−L−Val−L−Leu(O−Et)
15gをメタノール500mlに溶解し、触媒として10
%パラジウム担持カーボン2%を加え、室温で6時間、
水素ガスを注入して脱Z基化した。前記触媒を濾別し、
濾液を濃縮した後、得られたL−Val−L−Leu
(O−Et)をメシチレン(2,4,6−トリメチルベ
ンゼン)400mlに溶かし、5時間還流して環状化反応
を行わせた。該反応後、メシチレンを100mlまで濃縮
し、析出した結晶を濾紙で濾別し、石油エーテルで洗浄
後に減圧乾燥して粗生成物を得た。これをさらにエタノ
ール100mlで再結晶し、L−ロイシンとL−バリンと
が2個のアミド結合を介して六員環構造となった環状ジ
ペプチド〔以下、cyclo(L−Val−L−Le
u)と略す〕(試料No.1)10.2gを得た。ZL-Val-L-Leu (O-Et)
15 g was dissolved in 500 ml of methanol, and 10
% Palladium on carbon 2% and added at room temperature for 6 hours,
De-Z grouping was performed by injecting hydrogen gas. Filtering off the catalyst,
After concentrating the filtrate, the resulting L-Val-L-Leu was obtained.
(O-Et) was dissolved in 400 ml of mesitylene (2,4,6-trimethylbenzene) and refluxed for 5 hours to effect a cyclization reaction. After the reaction, mesitylene was concentrated to 100 ml, and the precipitated crystals were separated by filtration with filter paper, washed with petroleum ether and dried under reduced pressure to obtain a crude product. This was further recrystallized with 100 ml of ethanol to obtain a cyclic dipeptide in which L-leucine and L-valine had a six-membered ring structure through two amide bonds [hereinafter, cyclo (L-Val-L-Le).
u)] (Sample No. 1) (10.2 g) was obtained.
【0019】前記反応工程の概要を反応式で示すと式
(2)および式(3)で表される。The outline of the above reaction step is represented by the following formulas (2) and (3).
【化7】 Embedded image
【化8】 Embedded image
【0020】合成例2〜8 合成例1に記載の方法に準じて得たZ−L−Leu2
6.5gとL−ロイシンエチルエステル19.8gとを
用い、同様の方法で処理して、L−ロイシンどうしが2
個のアミド結合を介して六員環構造となった環状ジペプ
チド〔以下、cyclo(L−Leu−L−Leu)と
略す〕(試料No.2)21.2gを得た。さらに合成例
1と同様の方法により、各々が2個のアミド結合を介し
て六員環構造となったL−ロイシンとL−イソロイシン
との環状ジペプチド〔以下、cyclo(L−iLeu
−L−Leu)と略す〕(試料No.3) 、L−ロイシン
とL−フェニルアラニンとの環状ジペプチド〔以下、c
yclo(L−Phe−L−Leu)と略す〕(試料N
o.4) 、L−グリシンどうしの環状ジペプチド〔以
下、cyclo(L−Gly−L−Gly)と略す〕
(試料No.5) 、L−バリンどうしの環状ジペプチド
〔以下、cyclo(L−Val−L−Val)と略
す〕(試料No.6) 、L−フェニルアラニンどうしの環
状ジペプチド〔以下、cyclo(L−Phe−L−P
he)と略す〕(試料No.7) 、およびL−グリシンと
L−バリンとの環状ジペプチド〔以下、cyclo(L
−Val−L−Gly)と略す〕(試料No.8) を得
た。Synthesis Examples 2 to 8 ZL-Leu2 obtained according to the method described in Synthesis Example 1
Using 6.5 g and 19.8 g of L-leucine ethyl ester, the same treatment was carried out to obtain 2 L-leucine.
21.2 g of a cyclic dipeptide (hereinafter abbreviated as cyclo (L-Leu-L-Leu)) (sample No. 2) having a six-membered ring structure via two amide bonds was obtained. Further, in the same manner as in Synthesis Example 1, a cyclic dipeptide of L-leucine and L-isoleucine each having a six-membered ring structure via two amide bonds [hereinafter, cyclo (L-iLeu)
-L-Leu)] (Sample No. 3), a cyclic dipeptide of L-leucine and L-phenylalanine [hereinafter, c
yclo (L-Phe-L-Leu)] (Sample N
o. 4) a cyclic dipeptide of L-glycines [hereinafter abbreviated as cyclo (L-Gly-L-Gly)]
(Sample No. 5), cyclic dipeptide of L-valine [hereinafter abbreviated as cyclo (L-Val-L-Val)] (Sample No. 6), cyclic dipeptide of L-phenylalanine [hereinafter, cyclo (L -Phe-LP
he)) (Sample No. 7), and a cyclic dipeptide of L-glycine and L-valine [hereinafter, cyclo (L)
-Val-L-Gly)] (Sample No. 8).
【0021】実施例1 L−ロイシンとL−バリンとの環状ジペプチド〔cyc
lo(L−Val−L−Leu)、試料No.1〕の、有
機溶媒あるいは油脂類に対するゲル化能を次の方法で調
べた。すなわち、蓋付き試験管に前記環状ジペプチドを
300mg、有機溶媒または油脂類を10ml採り、加熱、
溶解した後、25℃に冷却したときの状態を観察した。
内容物全体がゲル状を呈し、試験管を傾けたときに液状
物が滲出せず、かつ流動化しないものをゲルとし、ゲル
になったものについてはさらにその臨界ゲル化濃度(有
機溶媒または油脂類1mlをゲル化させるために必要な環
状ジペプチドの最少重量:gの百分率、単位は重量/容
量%、以下CGCという。)を求めた。その結果、cy
clo(L−Val−L−Leu)(試験No.1)のC
GCは、クロロホルムに対して1.6重量/容量%、ト
ルエンに対して2.0重量/容量%であり、有機溶媒に
対してゲル化能を有し、本発明のゲル化剤として適する
ことが認められた。また、得られたゲルはいずれも均一
で滑らかな感触であった。EXAMPLE 1 Cyclic dipeptide of L-leucine and L-valine [cyc
lo (L-Val-L-Leu), sample no. The gelling ability of 1) for organic solvents or fats and oils was examined by the following method. That is, 300 mg of the cyclic dipeptide and 10 ml of an organic solvent or fats and oils were taken in a test tube with a lid, and heated.
After dissolution, the state when cooled to 25 ° C. was observed.
The entire content is in a gel state, and when the test tube is tilted, the liquid substance does not exude and does not fluidize. The gel is used as the gel. For the gelled substance, the critical gelation concentration (organic solvent or oil / fat The minimum weight of the cyclic dipeptide required to gel 1 ml of the class (percentage of g, unit is weight / volume%, hereinafter referred to as CGC) was determined. As a result, cy
Clo (L-Val-L-Leu) (Test No. 1) C
GC is 1.6% by weight / volume with respect to chloroform and 2.0% by weight / volume with respect to toluene, has a gelling ability with respect to an organic solvent, and is suitable as the gelling agent of the present invention. Was observed. In addition, all of the obtained gels had a uniform and smooth feel.
【0022】実施例2 実施例1と同様の方法により、cyclo(L−Leu
−L−Leu)(試料No.2)の、有機溶媒あるいは油
脂類に対するゲル化能を調べたところ、そのCGCは四
塩化炭素に対して2.0重量/容量%、ベンゼンに対し
て0.4重量/容量%、トルエンに対して0.9重量/
容量%、および大豆油に対して0.2重量/容量%であ
った。このことから、cyclo(L−Leu−L−L
eu)は有機溶媒および油脂類に対してゲル化能を有
し、また得られたゲルはいずれも均一で滑らかな感触で
あり、本発明のゲル化剤として適することが認められ
た。Example 2 Cyclo (L-Leu) was obtained in the same manner as in Example 1.
-L-Leu) (Sample No. 2) was examined for its gelling ability with respect to organic solvents or fats and oils, and its CGC was 2.0% by weight / volume with respect to carbon tetrachloride and 0.2% with respect to benzene. 4% weight / volume, 0.9% weight / toluene
% By volume, and 0.2% w / v based on soybean oil. From this, cyclo (L-Leu-LL-L)
eu) has a gelling ability with respect to organic solvents and fats and oils, and the obtained gels have a uniform and smooth feel, which proved to be suitable as the gelling agent of the present invention.
【0023】実施例3 実施例1と同様の方法により、cyclo(L−iLe
u−L−Leu)(試料No.3) の、有機溶媒あるいは
油脂類に対するゲル化能を調べたところ、そのCGCは
四塩化炭素に対して1.8重量/容量%、ベンゼンに対
して0.4重量/容量%、トルエンに対して1.1重量
/容量%および大豆油に対して0.3重量/容量%であ
った。この結果から、cyclo(L−iLeu−L−
Leu)は有機溶媒および油脂類に対してゲル化能を有
し、また得られたゲルはいずれも均一で滑らかな感触で
あり、本発明のゲル化剤として適することが明らかにな
った。Example 3 Cyclo (L-iLe) was obtained in the same manner as in Example 1.
When the gelling ability of u-L-Leu) (sample No. 3) with respect to organic solvents or fats and oils was examined, its CGC was 1.8% by weight / volume with respect to carbon tetrachloride and 0% with respect to benzene. 0.4% w / v, 1.1% w / v based on toluene and 0.3% w / v based on soybean oil. From this result, cyclo (L-iLeu-L-
Leu) has a gelling ability with respect to organic solvents and fats and oils, and the resulting gels have a uniform and smooth feel, which proved to be suitable as the gelling agent of the present invention.
【0024】実施例4 実施例1と同様の方法により、cyclo(L−Phe
−L−Leu)(試料No.4) の、有機溶媒あるいは油
脂類に対するゲル化能を調べたところ、そのCGCはア
セトンに対して2.0重量/容量%、酢酸エチルに対し
て2.0重量/容量%、クロロホルムに対して2.0重
量/容量%、ベンゼンに対して2.0重量/容量%、ト
ルエンに対して0.5重量/容量%、メトキシベンゼン
に対して0.3重量/容量%、クロルベンゼンに対して
0.3重量/容量%、ニトロベンゼンに対して0.3重
量/容量%、トリカプリリンに対して0.2重量/容量
%、トリオレインに対して0.2重量/容量%、および
大豆油に対して0.1重量/容量%であった。この結果
から、cyclo(L−Phe−L−Leu)は有機溶
媒および油脂類に対してゲル化能を有し、また得られた
ゲルはいずれも均一で滑らかな感触であり、本発明のゲ
ル化剤として適することが明らかになった。Example 4 Cyclo (L-Phe) was obtained in the same manner as in Example 1.
-L-Leu) (Sample No. 4) was examined for gelling ability with respect to organic solvents or fats and oils, and its CGC was 2.0% by weight / volume with respect to acetone and 2.0% with respect to ethyl acetate. Wt / vol%, 2.0 wt / vol% for chloroform, 2.0 wt / vol% for benzene, 0.5 wt / vol% for toluene, 0.3 wt for methoxybenzene / Vol%, 0.3 wt / vol% for chlorobenzene, 0.3 wt / vol% for nitrobenzene, 0.2 wt / vol% for tricaprylin, 0.2 wt% for triolein % W / v, and 0.1% w / v based on soybean oil. From these results, it is clear that cyclo (L-Phe-L-Leu) has a gelling ability with respect to organic solvents and fats and oils, and that the resulting gels have a uniform and smooth feel. It proved to be suitable as an agent.
【0025】実施例5 cyclo(L−Val−L−Leu)(試料No.1) :
40%、cyclo(L−Leu−L−Leu)(試料
No.2):40%および12−ヒドロキシステアリン酸:
20%からなる混合物を80℃に加熱して均一に混ぜ、
室温まで冷却した。これを3重量/容量%および8重量
/容量%含む有機溶媒あるいは油脂類を調製し、実施例
1と同様の方法によりゲル形成の有無を調べたところ、
クロロホルム、四塩化炭素、ベンゼン、トルエン、トリ
オレインおよび大豆油について、いずれも均一で滑らか
な感触のゲルが得られることを認めた。Example 5 Cyclo (L-Val-L-Leu) (Sample No. 1):
40%, cyclo (L-Leu-L-Leu) (sample
No. 2): 40% and 12-hydroxystearic acid:
Heat the mixture consisting of 20% to 80 ° C and mix evenly,
Cooled to room temperature. Organic solvents or fats and oils containing 3% by weight and 8% by weight of this were prepared, and the presence or absence of gel formation was examined by the same method as in Example 1.
For chloroform, carbon tetrachloride, benzene, toluene, triolein and soybean oil, it was recognized that a gel having a uniform and smooth feel was obtained.
【0026】実施例6 cyclo(L−Phe−L−Leu)(試料No.
4):50%、12−ヒドロキシステアリン酸:30
%、ヒマワリワックス:10%およびミツロウ10%か
らなる混合物を80℃に加熱して均一に混ぜ、室温まで
冷却した。実施例1と同様の方法により、これを1重量
/容量%、7重量/容量%および10重量/容量%含む
有機溶媒あるいは油脂類を調製し、各々のゲル形成の有
無を調べた。その結果、アセトン、酢酸エチル、クロロ
ホルム、ベンゼン、トルエン、メトキシベンゼン、クロ
ルベンゼン、ニトロベンゼン、トリカプリリン、トリオ
レイン、大豆油および菜種油について、いずれも均一で
滑らかな感触のゲルが得られることを認めた。Example 6 Cyclo (L-Phe-L-Leu) (Sample No.
4): 50%, 12-hydroxystearic acid: 30
%, Sunflower wax: 10% and beeswax 10% were heated to 80 ° C., mixed uniformly, and cooled to room temperature. In the same manner as in Example 1, organic solvents or fats and oils containing 1% by weight, 7% by weight, and 10% by weight / volume were prepared, and the presence or absence of gel formation was examined. As a result, for acetone, ethyl acetate, chloroform, benzene, toluene, methoxybenzene, chlorobenzene, nitrobenzene, tricaprylin, triolein, soybean oil, and rapeseed oil, it was confirmed that a gel having a uniform and smooth feel was obtained. .
【0027】比較例1 アセトン、酢酸エチル、クロロホルム、四塩化炭素、ベ
ンゼン、トルエン、メトキシベンゼン、クロルベンゼ
ン、ニトロベンゼン、トリカプリリン、トリオレインお
よび大豆油に、12−ヒドロキシステアリン酸を各1.
0重量/容量%添加し、実施例1と同様の方法によりゲ
ル化能を調べたところ、前記有機溶媒には溶解せず、ま
た油脂類には溶解するものの粘性のある流動状態を示
し、いずれからも均一なゲルは得られなかった。さらに
前記油脂類に対して12−ヒドロキシステアリン酸を
2.0重量/容量%添加して同様にゲル化能を調べたと
ころ、ゲルは得られるが、ボソつきのあるもろいゲルで
あった。Comparative Example 1 12-hydroxystearic acid was added to acetone, ethyl acetate, chloroform, carbon tetrachloride, benzene, toluene, methoxybenzene, chlorobenzene, nitrobenzene, tricaprylin, triolein and soybean oil in the same manner as in soybean oil.
When 0% (w / v) was added and the gelling ability was examined in the same manner as in Example 1, the gelling ability was not dissolved in the organic solvent and dissolved in fats and oils, but showed a viscous fluid state. Did not give a uniform gel. Further, when the gelling ability was similarly examined by adding 2.0% by weight / volume of 12-hydroxystearic acid to the fats and oils, a gel was obtained, but the gel was brittle and brittle.
【0028】比較例2 実施例1と同様の方法により、cyclo(L−Gly
−L−Gly)(試料No.5) 、cyclo(L−Va
l−L−Val)(試料No.6) 、cyclo(L−P
he−L−Phe)(試料No.7)およびcyclo
(L−Val−L−Gly)(試料No.8) の、有機溶
媒あるいは油脂類に対するゲル化能を調べた結果、これ
らの環状ジペプチドはいずれも、比較例1に記載の有機
溶媒および油脂類に対して不溶または結晶となり、本発
明の目的とする均一で滑らかなゲルを形成しなかった。Comparative Example 2 Cyclo (L-Gly) was prepared in the same manner as in Example 1.
-L-Gly) (Sample No. 5), cyclo (L-Va)
IL-Val) (Sample No. 6), cyclo (LP)
he-L-Phe) (Sample No. 7) and cyclo
As a result of examining the gelling ability of (L-Val-L-Gly) (Sample No. 8) with respect to organic solvents or fats and oils, any of these cyclic dipeptides was found to be the organic solvent and fats and oils described in Comparative Example 1. , And did not form a uniform and smooth gel which was the object of the present invention.
【0029】[0029]
【発明の効果】本発明によれば、各種有機溶媒とりわけ
ハロゲン系および芳香族系溶媒、とくにベンゼン系溶
媒、または油脂類に対してゲル化能が優れ、均一で滑ら
かなゲルを形成するゲル化剤を提供できる。According to the present invention, a gelling agent having an excellent gelling ability with respect to various organic solvents, especially a halogen-based solvent and an aromatic solvent, particularly a benzene-based solvent, or an oil or fat, to form a uniform and smooth gel. Agent can be provided.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) C09K 3/00 103 C11B 15/00 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int. Cl. 6 , DB name) C09K 3/00 103 C11B 15/00 CA (STN) REGISTRY (STN)
Claims (4)
イシンおよびフェニルアラニンからなる群より選ばれる
1種との下記一般式(1)で示される環状ジペプチドを
有効成分とする有機溶媒あるいは油脂類のゲル化剤。 【化1】 〔ただし式(1)中、Aは(CH3 )2 CH、(C
H3 )2 CHCH2 、(C2H5 )(CH3 )CHまた
は 【化2】 である。〕1. A gelling agent for organic solvents or fats and oils containing leucine and one selected from the group consisting of valine, leucine, isoleucine and phenylalanine as an active ingredient, comprising a cyclic dipeptide represented by the following general formula (1): . Embedded image [However, in the formula (1), A is (CH 3 ) 2 CH, (C
H 3 ) 2 CHCH 2 , (C 2 H 5 ) (CH 3 ) CH or It is. ]
2 CH、(CH3 )2CHCH2 または 【化3】 である請求項1に記載のゲル化剤。2. In the general formula (1), A is (CH 3 )
2 CH, (CH 3 ) 2 CHCH 2 or The gelling agent according to claim 1, which is:
ン系溶媒である請求項1に記載のゲル化剤。4. The gelling agent according to claim 1, wherein the organic solvent is a halogen-based solvent or a benzene-based solvent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6787494A JP2921730B2 (en) | 1994-03-10 | 1994-03-10 | Gelling agent for organic solvents or fats and oils |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6787494A JP2921730B2 (en) | 1994-03-10 | 1994-03-10 | Gelling agent for organic solvents or fats and oils |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH07247473A JPH07247473A (en) | 1995-09-26 |
| JP2921730B2 true JP2921730B2 (en) | 1999-07-19 |
Family
ID=13357510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6787494A Expired - Fee Related JP2921730B2 (en) | 1994-03-10 | 1994-03-10 | Gelling agent for organic solvents or fats and oils |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2921730B2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004182696A (en) * | 2002-12-05 | 2004-07-02 | Shiseido Co Ltd | External preparation composition |
| JP2004262857A (en) * | 2003-03-03 | 2004-09-24 | Shiseido Co Ltd | External preparation composition |
| JP2004262859A (en) * | 2003-03-03 | 2004-09-24 | Shiseido Co Ltd | External preparation composition |
| JP2004269459A (en) * | 2003-03-11 | 2004-09-30 | Nippon Unicar Co Ltd | Oily cosmetic containing amino acid derivative-modified silicone |
| AU2003235960A1 (en) | 2003-04-28 | 2004-11-23 | Ajinomoto Co., Inc. | Two-headed basic amino acid derivative |
| JP4765256B2 (en) * | 2004-03-11 | 2011-09-07 | コニカミノルタホールディングス株式会社 | Actinic ray curable inkjet ink and inkjet recording method using the same |
| JP5376290B2 (en) | 2008-09-24 | 2013-12-25 | 国立大学法人静岡大学 | Urea compound, self-assembly of urea compound, organogel containing self-assembly, and method for producing organogel |
-
1994
- 1994-03-10 JP JP6787494A patent/JP2921730B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07247473A (en) | 1995-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2921731B2 (en) | Gelling agents for organic solvents or fats and oils | |
| EP0105777B1 (en) | Lipopeptides, their manufacture and use as emulsifiers | |
| Turk et al. | . alpha.-Methyl amino acids. Resolution and amino protection | |
| FR2458538A1 (en) | NONAPEPTIDE AND DECAPEPTITIVE DERIVATIVES OF LUTEINIZING HORMONE-FREE HORMONE, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | |
| EP0517589A2 (en) | Tachykinin derivatives, their preparation and pharmaceutical compositions containing them | |
| JP2921730B2 (en) | Gelling agent for organic solvents or fats and oils | |
| FR2460291A1 (en) | NOVEL TRIPEPTIDES ACTING ON THE CENTRAL NERVOUS SYSTEM AND THEIR PREPARATION PROCESS | |
| WO2019198834A1 (en) | Method for producing leuprorelin | |
| JP2921732B2 (en) | Gelling agents for organic solvents or fats and oils | |
| BE897844A (en) | BIOLOGICALLY ACTIVE TRIPEPTIDES AND TETRAPEPTIDES ALKYLAMIDES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS | |
| CN1462277A (en) | Pharmaceutical composition comprising analgesic peptide | |
| SU1396970A3 (en) | Method of producing derivatives of gonadoliberine | |
| CN1041524C (en) | Oligopeptides derived from C-reactive protein fragments | |
| EP0292729A2 (en) | Process for solid phase peptide synthesis | |
| De Marco et al. | Easy preparation of dehydroalanine building blocks equipped with oxazolidin-2-one chiral auxiliaries, and applications to the stereoselective synthesis of substituted tryptophans | |
| JP2010513492A (en) | Preparation of 3- (amino) -3- (cyclobutylmethyl) -2- (hydroxy) -propionamide hydrochloride | |
| FR2595705A1 (en) | GONADOLIBERIN DERIVATIVES CONTAINING AROMATIC AMINOCARBOXYLIC ACID IN POSITION 6, PHARMACEUTICAL AND VETERINARY COMPOSITIONS CONTAINING SAME AND PROCESS FOR PREPARING THE SAME | |
| FR2491922A1 (en) | NOVEL HEXAPEPTIDES, PROCESS FOR THEIR PREPARATION AND APPLICATION AS MEDICAMENTS | |
| JP3061348B2 (en) | Gelling agents for organic solvents and / or fats and oils | |
| CN116396357A (en) | A kind of synthesis method of peptide with neuroprotective function | |
| JPS59219259A (en) | Gonadoliverin derivatives | |
| US20110301376A1 (en) | Preparation of crystalline ezatiostat hydrochloride ansolvate form d | |
| JP5097104B2 (en) | New isodipeptide | |
| JP2900526B2 (en) | Enzyme activator | |
| EP0564587A1 (en) | Solution phase process for synthesis of peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |